Want to see RAPP full AI Analyst Report?
Rapport Therapeutics, Inc. (RAPP) Ownership Overview
22.49% Insiders
24.40% Mutual Funds
4.23% Other Institutional Investors
8.98% ETFs
39.91% Public Companies and
Individual Investors
The ownership structure of Rapport Therapeutics, Inc. (RAPP) stock is a mix of institutional, retail, and individual investors. Approximately 37.60% of the company’s stock is owned by Institutional Investors, 22.49% is owned by Insiders, and 39.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 09, 2026 | xxxxxxxxxxxxx | $58265 | |
Sep 15, 2025 | xxxxxxxxxxxxx | $499188 | |
Sep 15, 2025 | xxxxxxxxxxxxx | $1026824 | |
Sep 11, 2025 | xxxxxxxxxxxxx | $79100 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,249,743 | Insider | 15.16% | 297,094,468 | |
| 3,634,580 | Institution | 7.60% | 148,945,088 | |
| 3,152,816 | Institution | 6.59% | 129,202,400 | |
| 1,995,594 | Insider | 4.17% | 81,779,442 | |
| 1,677,959 | Institution | 3.51% | 68,762,760 | |
| 1,649,858 | Institution | 3.45% | 67,611,181 | |
| 1,547,090 | Institution | 3.23% | 63,399,748 | |
| 1,292,696 | Institution | 2.70% | 52,974,682 | |
| 756,773 | Institution | 1.58% | 31,012,558 | |
| 673,923 | Institution | 1.41% | 27,617,365 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,634,580 | Institution | 7.60% | 148,945,088 | |
| 3,152,816 | Institution | 6.59% | 129,202,400 | |
| 1,292,696 | Institution | 2.70% | 52,974,682 | |
| 756,773 | Institution | 1.58% | 31,012,558 | |
| 601,105 | Institution | 1.26% | 24,633,283 | |
| 364,351 | Institution | 0.76% | 14,931,104 | |
| 331,722 | Institution | 0.69% | 13,593,968 | |
| 305,167 | Institution | 0.64% | 12,505,744 | |
| 297,702 | Institution | 0.62% | 12,199,828 | |
| 164,405 | Institution | 0.34% | 6,737,317 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 986,730 | Institution | 2.06% | 41,117,039 | |
| 782,204 | Institution | 1.64% | 35,582,460 | |
| 328,506 | Institution | 0.69% | 13,688,845 | |
| 257,826 | Institution | 0.54% | 11,728,505 | |
| 209,659 | Institution | 0.44% | 9,537,388 | |
| 176,323 | Institution | 0.37% | 7,347,379 | |
| 169,945 | Institution | 0.36% | 7,876,951 | |
| 137,043 | Institution | 0.29% | 6,351,943 | |
| 110,173 | Institution | 0.23% | 4,675,742 | |
| 103,994 | Institution | 0.22% | 4,730,687 |
FAQ
Who Owns Rapport Therapeutics, Inc. (RAPP)?
According to the latest TipRanks data, approximately 4.23% of the company's stock is held by institutional investors, 22.49% is held by insiders, and 39.91% is held by retail investors.
What percentage of Rapport Therapeutics, Inc. (RAPP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.23% of Rapport Therapeutics, Inc. (RAPP) stock is held by institutional investors.
What percentage of Rapport Therapeutics, Inc. (RAPP) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.91% of Rapport Therapeutics, Inc. (RAPP) stock is held by retail investors.
Who owns the most shares of Rapport Therapeutics, Inc. (RAPP)?
Third Rock Ventures V, L.P. owns the most shares of Rapport Therapeutics, Inc. (RAPP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.